Illness	Number of cases
Atrial fibrillation and flutter (I48.1)	292
Atrial fibrillation and flutter - Paroxysmal atrial fibrillation (I48.0)	211
Chronic ischaemic heart disease (I25.13)	207
Left ventricular failure unspecified (I50.13)	200
Essential primary hypertension (I10.01)	188
Unstable angina (I20.0)	187
Chronic ischaemic heart disease (I25.11)	173
Chronic ischaemic heart disease (I25.12)	171
Syncope and collapse (R55)	153
Heart failure (I50.01)	131

Top 10 treatments

Treatment	Number
Complex differential diagnostic sonography using Tissue Doppler Imaging [TDI] and deformation analysis of tissue [speckle tracking] (3-034)	1.682
Examination of the left side of the heart with a tube (catheter) inserted into the heart via an artery (1-275.0)	1.179
Additional information on materials used (8-83b.0c)	792
Computer-assisted analysis of the images with 3D-analysis (3-990)	650
Ultrasound of the heart (echocardiography) through the oesophagus - TEE (3-052)	555
Treatment of the heart and/or the coronary arteries with access through a tube (catheter) along the blood vessels (8-837.00)	505
Intensive care monitoring of respiration, the heart and the circulation without measurement of the pressure in the pulmonary artery and in the right atrium of the heart (8-930)	479
Treatment of cardiac arrhythmias with electric shocks - defibrillation (8-640.0)	449
Ultrasound scanning of the blood vessels after the insertion of an ultrasound probe into the vessels (3-05g.0)	447
Additional information on materials used (8-83b.c6)	432

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 0300

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law

Bezeichnung
Teilnahme externe Qualitätssicherung	0

Quality of participation in the Disease Management Programme (DMP)
No participation

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
No participation

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
23	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
17	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
17	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Project-related cooperation with colleges and universities
Participation in multi-centre phase III/IV studies
Lectureships / teaching posts at colleges and universities	an der Ludwig-Maximilians-Universität München und der TU München (TUM)
Doctoral supervision
Editors of scientific journals/textbooks
Initiation and management of uni-centric/multi-centric clinical/scientific studies
Student training (clinical traineeship / internship year)	inklusiv klinische Untersuchungskurse für Student*innen an der Ludwig-Maximilians-Universität München und der TU München (TUM)